Mandana Kamgar, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy (NCT05630989) | Mandana Kamgar, MD | 2023-02-07 |
Track Mandana Kamgar, MD automatically
Every clearance here is in the API, with alerts when new ones post.